limited due to its low selectivity and tedium. Recently,
considerable effort has been devoted to develop transition
metals, in particular, palladium-catalyzed domino reactions
for the synthesis of 3-methyleneindolin-2-ones to solve these
drawbacks (Scheme 1).3,5 However, most of these reactions
is of considerable importance. Very recently, we developed
a novel protocol for constructing two bonds, a C-C bond
and a C-N bond, via a sequential intermolecular aminopal-
ladation/ortho-arene C-H activation process (eq 3 in Scheme
1).4 As a continuing interest in constructing the oxindole
skeleton, we report herein that (2-oxoindolin-3-ylidene)-
methyl acetates could be prepared successfully by the
acetoxypalladation/C-H functionalization of anilides in the
presence of PhI(OAc)2.
Scheme 1. Three Protocols for the Synthesis of Oxindoles
Table 1. Screening Conditionsa
entry
PhI(OAc)2 (equiv)
solvent
time (h)
yield (%)b
1c
2d
3e
4
5
6
2.0
2.0
2.0
2.0
2.0
1.2
1.2
1.2
1.2
1.2
MeCN
MeCN
MeCN
MeCN
HOAc
HOAc
HOAc
HOAc
HOAc
HOAc
10
10
10
10
2
2
5
5
2
trace
56
80
89
91
90
89
0
require the use of 2-haloanilides or 2-(alkynyl)phenylisocy-
anates as the starting materials (eq 1 in Scheme 1). An
interesting approach is the palladium-catalyzed domino
carbopalladation/C-H activation/C-C bond-forming reac-
tion that uses an anilide sp2 C-H bond as one of the coupling
partners (eq 2).3c,d Although all the reported palladium-
catalyzed transformations provided an efficient and selective
route to the synthesis of methylenyloxindoles, only carbon
atoms were introduced to the triple bonds to form two
carbon-carbon bonds in all cases.3
7f
8g
9h
10i
38
88
2
a Reaction conditions: 1 (0.2 mmol), Pd(OAc)2 (10 mol %), PhI(OAc)2
and HOAc (10 equiv) in solvent (3 mL) at 80 °C. b Isolated yield. c Without
HOAc, a 17% yield of 1-methyl-3-(diphenylmethylene)indolin-2-one (4)
was isolated. d HOAc (2 equiv). A 6% yield of 4 was isolated. e HOAc (5
equiv). f Pd(OAc)2 (5 mol %). g Without Pd(OAc)2. h At room temperature.
i At 100 °C.
Many bioactive 3-methyleneindolin-2-ones include the
carbon-heteroatom bonds at the terminal of the 3-methylene
group.1f–h Tenidap (commercialized in 1993; Pfizer, Inc.),
for instance, is an anti-inflammatory medicine for the therapy
of arthritis, etc. (Figure 1).1f Thus, the development of new
palladium-catalyzed routes to synthesize these indolin-2-ones
As demonstrated in Table 1, N-methyl-N,3-diphenylpro-
piolamide (1) was employed as the starting substrate to
explore the optimal conditions.5 Initially, the amount of
HOAc was examined, and the results showed that the amount
of HOAc has a fundamental influence on the reaction in
terms of yield and rate (entries 1-5). Without HOAc, a trace
amount of the target acetoxypalladation product 3 was
detected by GC-MS analysis from the reaction of amide 1
with Pd(OAc)2 and PhI(OAc)2 in MeCN (entry 1), and the
product 3 was enhanced sharply to 56% in the presence of
2 equiv of HOAc (entry 2).6 In the presence of 5 equiv of
HOAc, the yield of 3 was increased to 80% (entry 3). To
our delight, substrate 1 was consumed completely in 2 h,
providing a 91% yield using HOAc as the medium (entry
5). We were happy to discover that a good yield of 3 was
still isolated even in the presence of 1.2 equiv of PhI(OAc)2
using HOAc as the medium (entry 6). Noteworthy is that
the reaction can be conducted in good yields even at a
loading of 5 mol % of Pd after prolonged reaction time (entry
(2) (a) Mori, M.; Ban, Y. Tetrahedron Lett. 1979, 20, 1133. (b) Sun,
L.; Liang, C.; Shirazian, S.; Zhou, Y.; Miller, T.; Cui, J.; Fukuda, J. Y.;
Chu, J.-Y.; Nematalla, A.; Wang, X.; Chen, H.; Sistla, A.; Luu, T. C.; Tang,
F.; Wei, J.; Tang, C. J. Med. Chem. 2003, 46, 1116. (c) Wang, L.; Zhang,
Y.; Hu, H.-Y.; Fun, H. K.; Xu, J.-H. J. Org. Chem. 2005, 70, 3805. (d)
Kalinski, C.; Umkehrer, M.; Schmidt, J.; Ross, G.; Kolb, J.; Burdack, C.;
Hiller, W.; Hoffmann, S. D. Tetrahedron Lett. 2006, 47, 4683. (e) Xing,
X.; Wu, J.; Luo, J.; Dai, W.-M. Synlett 2006, 2099. (f) Yang, T.-M.; Liu,
G. J. Comb. Chem. 2007, 9, 86
.
(3) Pd: (a) Cheung, W. S.; Patch, R. J.; Player, M. R. J. Org. Chem.
2005, 70, 3741. (b) Yanada, R.; Obika, S.; Inokuma, T.; Yanada, K.;
Yamashita, M.; Ohta, S.; Takemoto, Y. J. Org. Chem. 2005, 70, 6972. (c)
Pinto, A.; Neuville, L.; Retailleau, P.; Zhu, J. Org. Lett. 2006, 8, 4927. (d)
Pinto, A.; Neuville, L.; Zhu, J. Angew. Chem., Int. Ed. 2007, 46, 3291. (e)
Couty, S.; Lie´gault, B.; Meyer, C.; Cossy, J. Org. Lett. 2004, 6, 2511. (f)
D’Souza, D. M.; Rominger, F.; Mu¨ller, T. J. J. Angew. Chem., Int. Ed.
2005, 44, 153. (g) Tang, S.; Yu, Q.-F.; Peng, P.; Li, J.-H.; Zhong, P.; Tang,
R.-Y. Org. Lett. 2007, 9, 3413. In/Pd: (h) Yanada, R.; Obika, S.; Oyama,
M.; Takemoto, Y. Org. Lett. 2004, 6, 2825. Rh: (i) Shintani, R.; Yamagami,
T.; Hayashi, T. Org. Lett. 2006, 8, 4799. (j) Miura, T.; Takahashi, Y.;
Murakami, M. Org. Lett. 2007, 8, 5075
(4) Tang, S.; Peng, P.; Pi, S.-F.; Liang, Y.; Wang, N.-X.; Li, J.-H. Org.
Lett. 2008, 10, 1179
(5) The detailed experimental data are summarized in Table S1 in
.
(6) The structure of the products and the E-configuration of the
tetrasubstituted double bond were determined according to the COSY and
NOESY of the products 12 and 16 and were unambiguously assigned by
X-ray analysis of the products 9 and 14 (see Supporting Information).
.
Supporting Information
.
1876
Org. Lett., Vol. 10, No. 9, 2008